Skip to main content
Equibles

Velan Capital Investment Management LP

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1848809 ALPHARETTA, GA
Back to JSPR Full portfolio

Position in JSPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,123,394
-$1,214,119 QoQ
Shares Held
2,668,395
0.0% QoQ
Ownership
8.02%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#1
of 44 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 91% Shared 9% None 0%

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. JSPR ranks #20 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 88,781 $29,722,990
2 MPLT
MapLight Therapeutics, Inc.
 492,893 $17,665,285
3 STRO
Sutro Biopharma, Inc.
 512,160 $17,003,712
4 IMMX
Immix Biopharma, Inc.
 1,085,000 $11,186,350
5 TARA
Protara Therapeutics, Inc.
 2,844,652 $10,866,570
6 ABVX
Abivax S.A.
 65,630 $8,745,853
7 TENX
Tenax Therapeutics, Inc.
 549,985 $8,002,281
8 EDSA
Edesa Biotech, Inc.
 827,500 $6,727,575

All Filings in JSPR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,123,394 2,668,395
2026-03-31 $2,337,513 2,668,395
2025-12-31 $4,883,162 2,668,395
2025-09-30 $6,350,779 2,668,395
2025-06-30 $7,957,745 1,433,828
2025-03-31 $6,165,460 1,433,828
2024-12-31 $30,655,242 1,433,828
2024-09-30 $26,970,304 1,433,828
2024-06-30 $33,412,220 1,471,904
2024-03-31 $43,215,101 1,471,904
2023-12-31 $8,851,819 11,219,036
2023-09-30 $7,853,325 11,219,036
2023-06-30 $15,370,079 11,219,036
2023-03-31 $20,306,455 11,219,036
2022-12-31 $1,554,794 3,219,036
2022-09-30 $2,539,819 3,219,036
2022-06-30 $6,212,739 3,219,036
2022-03-31 $11,427,577 3,219,036
2021-12-31 $25,269,432 3,219,036